Login / Signup

C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease.

Zhi-Hao WangKe GongXia LiuZhentao ZhangXiaoou SunZheng Zachory WeiShan Ping YuFredric P ManfredssonIvette M SandovalPeter F JohnsonJianping JiaJian-Zhi WangKeqiang Ye
Published in: Nature communications (2018)
Delta-secretase cleaves both APP and Tau to mediate the formation of amyloid plaques and neurofibrillary tangle in Alzheimer's disease (AD). However, how aging contributes to an increase in delta-secretase expression and AD pathologies remains unclear. Here we show that a CCAAT-enhancer-binding protein (C/EBPβ), an inflammation-regulated transcription factor, acts as a key age-dependent effector elevating both delta-secretase (AEP) and inflammatory cytokines expression in mediating pathogenesis in AD mouse models. We find that C/EBPβ regulates delta-secretase transcription and protein levels in an age-dependent manner. Overexpression of C/EBPβ in young 3xTg mice increases delta-secretase and accelerates the pathological features including cognitive dysfunctions, which is abolished by inactive AEP C189S. Conversely, depletion of C/EBPβ from old 3xTg or 5XFAD mice diminishes delta-secretase and reduces AD pathologies, leading to amelioration of cognitive impairment in these AD mouse models. Thus, our findings support that C/EBPβ plays a pivotal role in AD pathogenesis via increasing delta-secretase expression.
Keyphrases
  • binding protein
  • transcription factor
  • poor prognosis
  • mouse model
  • cognitive impairment
  • cognitive decline
  • type diabetes
  • regulatory t cells
  • cerebrospinal fluid
  • insulin resistance
  • dna binding